- Home
- APOG vs TVTX Comparison
APOG vs TVTX Comparison
Compare APOG & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APOG
- TVTX
- Stock Information
- Founded
- APOG 1949
- TVTX 2008
- Country
- APOG United States
- TVTX United States
- Employees
- APOG N/A
- TVTX N/A
- Industry
- APOG Auto Parts:O.E.M.
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- APOG Consumer Discretionary
- TVTX Health Care
- Exchange
- APOG Nasdaq
- TVTX Nasdaq
- Market Cap
- APOG 1.7B
- TVTX 1.5B
- IPO Year
- APOG N/A
- TVTX N/A
- Fundamental
- Price
- APOG $57.60
- TVTX $19.46
- Analyst Decision
- APOG Hold
- TVTX Buy
- Analyst Count
- APOG 1
- TVTX 12
- Target Price
- APOG $62.00
- TVTX $24.58
- AVG Volume (30 Days)
- APOG 323.9K
- TVTX 1.2M
- Earning Date
- APOG 01-07-2025
- TVTX 02-13-2025
- Dividend Yield
- APOG 1.75%
- TVTX N/A
- EPS Growth
- APOG N/A
- TVTX N/A
- EPS
- APOG 4.47
- TVTX N/A
- Revenue
- APOG $1,377,140,000.00
- TVTX $203,447,000.00
- Revenue This Year
- APOG N/A
- TVTX $62.37
- Revenue Next Year
- APOG $2.11
- TVTX $61.74
- P/E Ratio
- APOG $12.88
- TVTX N/A
- Revenue Growth
- APOG N/A
- TVTX 57.08
- 52 Week Low
- APOG $49.58
- TVTX $5.12
- 52 Week High
- APOG $87.93
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- APOG 33.35
- TVTX 59.31
- Support Level
- APOG $49.58
- TVTX $16.80
- Resistance Level
- APOG $56.21
- TVTX $18.76
- Average True Range (ATR)
- APOG 2.83
- TVTX 0.95
- MACD
- APOG -0.45
- TVTX 0.09
- Stochastic Oscillator
- APOG 34.32
- TVTX 89.86
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. Its segments are Architectural Framing Systems; Architectural Glass; Architectural Services and Large-Scale Optical Technologies (LSO). It generates maximum revenue from the Architectural Framing Systems segment. The Architectural Framing Systems segment designs, engineers, fabricates, and finishes the aluminum frames used in customized aluminum and glass windows, curtainwall, storefront, and entrance systems comprising the outside skin and entrances of commercial, institutional, and others. Geographically, it derives a majority of its revenue from the United States.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.